1. Randomized phase 2 trial of NP001–a novel immune regulator: Safety and early efficacy in ALS. Issue 3 (June 2015) Authors: Miller, Robert G.; Block, Gilbert; Katz, Jonathan S.; Barohn, Richard J.; Gopalakrishnan, Vidhya; Cudkowicz, Merit; Zhang, Jane R.; McGrath, Michael S.; Ludington, Elizabeth; Appel, Stan H.; Azhir, Ari; Katz, Jonathan; Kushner, Giovanna; Wong, Cynthia; Engel, Maguerite; Forshew, Dallas; Osborne, ... Journal: Neurology Issue: Volume 2:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗